Literature DB >> 1326277

Marihuana attenuates the rise in plasma ethanol levels in human subjects.

S E Lukas1, R Benedikt, J H Mendelson, E Kouri, M Sholar, L Amass.   

Abstract

This study was conducted to determine if plasma ethanol levels are altered as a result of smoking marihuana. Fifteen healthy adult male volunteers who used ethanol and marihuana on a casual basis participated in this study. Subjects were randomly assigned to one of three groups: placebo, low-dose, or high-dose marihuana. The marihuana dose was held constant and each subject drank three different doses of ethanol on 3 separate days spaced at least 1 week apart. Subjects drank either placebo or ethanol at doses of 0.35 g/kg (7.60 mmol/kg) or 0.70 g/kg (15.19 mmol/kg). Thirty minutes after drinking they smoked either a placebo marihuana cigarette, or one containing either 1.26% or 2.53% delta 9-tetrahydrocannabinol. Plasma ethanol levels rose sharply after the 0.7 g/kg dose and peaked at 50 minutes after drinking began (78.25 +/- 4.95 mg/dl). When subjects smoked the high-dose marihuana cigarettes after the 0.7 g/kg dose of ethanol, peak plasma ethanols levels were only 54.80 +/- 8.32 mg/dl at 105 minutes after drinking began. These alterations in plasma ethanol levels paralleled a reduction in the duration of ethanol- and marihuana-induced subjective effects after high doses of both drugs. These data suggest that marihuana may alter ethanol bioavailability.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326277

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  16 in total

1.  An MR-compatible device for delivering smoked marijuana during functional imaging.

Authors:  Blaise deB Frederick; Kimberly P Lindsey; Lisa D Nickerson; Elizabeth T Ryan; Scott E Lukas
Journal:  Pharmacol Biochem Behav       Date:  2007-04-13       Impact factor: 3.533

2.  Daily Patterns of Marijuana and Alcohol Co-Use Among Individuals with Alcohol and Cannabis Use Disorders.

Authors:  Jane Metrik; Rachel L Gunn; Kristina M Jackson; Alexander W Sokolovsky; Brian Borsari
Journal:  Alcohol Clin Exp Res       Date:  2018-05-08       Impact factor: 3.455

Review 3.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 4.  Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).

Authors:  Lingtak-Neander Chan; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

5.  Effects of ethanol, Δ(9)-tetrahydrocannabinol, or their combination on object recognition memory and object preference in adolescent and adult male rats.

Authors:  Nicholas A Swartzwelder; M Louise Risher; Sabri H Abdelwahab; Anouska D'Abo; Amir H Rezvani; Edward D Levin; Wilkie A Wilson; H Scott Swartzwelder; Shawn K Acheson
Journal:  Neurosci Lett       Date:  2012-08-29       Impact factor: 3.046

Review 6.  Can cannabis be considered a substitute medication for alcohol?

Authors:  Meenakshi Sabina Subbaraman
Journal:  Alcohol Alcohol       Date:  2014-01-08       Impact factor: 2.826

7.  Binge and Cannabis Co-Use Episodes in Relation to White Matter Integrity in Emerging Adults.

Authors:  Natasha E Wade; Alicia M Thomas; Staci A Gruber; Susan F Tapert; Francesca M Filbey; Krista M Lisdahl
Journal:  Cannabis Cannabinoid Res       Date:  2020-02-27

8.  Co-use of Alcohol and Cannabis: A Review.

Authors:  Ali M Yurasek; Elizabeth R Aston; Jane Metrik
Journal:  Curr Addict Rep       Date:  2017-04-27

9.  College student knowledge of blackouts and implications for alcohol intervention: A qualitative analysis.

Authors:  Mary Beth Miller; Jennifer E Merrill; Samyukta Singh; Angelo M DiBello; Kate B Carey
Journal:  Psychol Addict Behav       Date:  2018-10-25

10.  Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships.

Authors:  Rebecca L Hartman; Timothy L Brown; Gary Milavetz; Andrew Spurgin; David A Gorelick; Gary Gaffney; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2015-08-10       Impact factor: 3.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.